Table 5 Neurological symptoms, status and assessment scales at presentation, 1st and 2nd follow-up
From: Identifying risks for severity of neurological symptoms in Hungarian West Nile virus patients
Neurological status, n (%) | ||||
|---|---|---|---|---|
At hospital admission (n = 66) | 1st Follow-up (60–90 days after discharge) (n = 43) | 2nd Follow-up (150–180 days after discharge) (n = 12) | ||
GCS | 13–15 | 62 (93.9) | – | – |
9–12 | 3 (4.5) | – | – | |
8 or less | 1 (1.5) | – | – | |
Meningitis | yes | 8 (12.1) | 0 (0) | 0 (0) |
no | 57 (86.4) | 43 (100) | 12 (100) | |
data unavailable | 1 (1.5) | 0 (0) | 0 (0) | |
Encephalitis | yes | 1 (1.5) | 0 (0) | 0 (0) |
no | 64 (97.1) | 43 (100) | 12 (100) | |
data unavailable | 1 (1.5) | 0 (0) | 0 (0) | |
Meningoencephalitis | yes | 38 (40.9) | 0 (0) | 0 (0) |
no | 27 (57.6) | 43 (100) | 12 (100) | |
data unavailable | 1 (1.5) | 0 (0) | 0 (0) | |
Acute flaccid paresis | yes | 9 (13.6) | 4 (9.3) | 0 (0) |
no | 57 (86.4) | 39 (90.7) | 12 (100) | |
Localisation of muscle weakness | none | 46 (69.7) | 36 (83.7) | 11 (91.7) |
lower body | 6 (9.1) | 3 (7.0) | 1 (8.3) | |
upper body | 3 (4.5) | 1 (2.3) | 0 (0) | |
lower body + upper body | 10 (15.2) | 3 (7.0) | 0 (0) | |
unconscious | 1 (1.5) | – | – | |
Degree of muscle weakness | 0 (normal) | 46 (69.7) | 36 (83.7) | 11 (91.7) |
1 | 11 (16.7) | 2 (4.7) | 0 (0) | |
2 | 3 (4.5) | 2 (4.7) | 1 (8.3) | |
3.25 | 4 (6.1) | 2 (4.7) | 0 (0) | |
4 | 1 (1.5) | 1 (2.3) | 0 (0) | |
unconscious | 1 (1.5) | – | – | |
Reflex involvement (decreased or absent) | no | 59 (89.4) | 38 (88.4) | 11 (91.7) |
yes | 5 (7.6) | 5 (11.6) | 1 (8.3) | |
unconscious | 1 (1.5) | – | – | |
data unavailable | 1 (1.5) | – | – | |
Sensory involvement (decreased or absent) | no | 61 (92.4) | 41 (95.3) | 11 (91.7) |
yes | 3 (4.5) | 2 (4.7) | 1 (8.3) | |
unconscious | 1 (1.5) | – | – | |
data unavailable | 1 (1.5) | – | – | |
Other Neurological symptoms | At hospital admission (n = 66) | 1st Follow-up (n = 43) | 2nd Follow-up (n = 12) | |
Headache | 46 (69.7) | 5 (11.6) | – | |
Dizziness | 30 (45.5) | 7 (16.2) | – | |
Confusion, altered mind status | 18 (27.3) | – | – | |
Tremor | 7 (10.6) | – | – | |
Diplopia | 4 (6.1) | – | – | |
Gait uncertainty | 3 (4.5) | 2 (4.65) | – | |
Speech disturbance | 4 (6.0) | – | – | |
Photophobia | 3 (4.5) | – | – | |
Assessment tools, n (%) | At hospital admission | 1st follow-up | 2nd follow-up | |
WNV-N Index | moderately severe | 44 (66.7) | 37 (86.0) | 11 (91.7) |
severe | 22 (33.3) | 6 (14.0) | 1 (8.3) | |
Modified Rankin Scale | moderately severe | 48 (72.7) | 37 (86.0) | 12 (100) |
severe | 18 (27.3) | 6 (14.0) | 0 (0) | |